Skip to content
NewsBlazeAU – Lifestyle
Author:
Business Wire
Massive Bio Announces Next-Generation Reticulum Nexus™ Product Suite at ASCO 2026
May 30, 2026
Exelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Non-Functional and Functional Neuroendocrine Tumors at ASCO 2026
May 30, 2026
Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community
May 30, 2026
Tempus Introduces ‘Preview’: Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results
May 30, 2026
Immunome Announces Detailed Phase 3 RINGSIDE Data for Varegacestat in Adults with Progressing Desmoid Tumors at the 2026 ASCO Annual Meeting
May 30, 2026
TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer
May 30, 2026
Tune Therapeutics Presents Positive Phase 1b/2a Proof of Concept Data on TUNE-401: a First-in-Class Epigenetic Silencer for Patients with Hepatitis B at EASL 2026
May 30, 2026
FCPT Announces Agreement to Acquire up to 102 Mission Pet Health Veterinary Properties for $268 Million
May 29, 2026
AVAV INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that AeroVironment, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
May 29, 2026
Shareholder Notice: Robbins LLP Informs Investors of the Lucid Group, Inc. Class Action
May 29, 2026
1
2
3
…
2,469
Next Page
→